NFE2L2 and cancer: To further explore the concept that NRF2 status and function in the cell could be a contributing determinant and basis of HER4 receptor expression and cellular sensitivity and response of some cancers to LAP and/or ERL, we developed an ERL resistant PEO1 cell line using a previously described approach [43–45].